ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000857.1|Ectoine_1 # 1 # 300 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.440	BGC0000857.1|Ectoine_1 	1	300	+	Loose	375	23.0978	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	21.85	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GGTACCGGTTATTCGTCACTGAGTTATTTGAAGCACTTTCCGGTTGATACGCTGAAAATTGATAAATCGTTTGTGGCTGAAATTGTCTTTAACTCTGCAGATGCGGCCATTGCACGGACCATTATCCAGCTGGCGGAAAATTTAGGATTAAACACGGTGGCAGAAGGAGTTGAAACGCTGGATCAAGCCGACTTATTACGCAAAATGCAGTGTCATATTTTGCAGGGATTTTATTTCAGCAAACCCTTGCCGGTAGCGCAGGCGGAACAATTACTCAAAAACTGGCTACAACTGAGTTAG	GTGYSSLSYLKHFPVDTLKIDKSFVAEIVFNSADAAIARTIIQLAENLGLNTVAEGVETLDQADLLRKMQCHILQGFYFSKPLPVAQAEQLLKNWLQLS	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	46.05	gnl|BL_ORD_ID|2090|hsp_num:0	2306			210	537	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
BGC0000857.1|Ectoine_2 # 301 # 867 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.492	BGC0000857.1|Ectoine_2 	301	867	-	Loose	270	56.6102	mgrA	33.33	3000815	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; penam; tetracycline antibiotic; peptide antibiotic; disinfecting agents and antiseptics	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAAAAGTCAGACAATCGCAATACAACCAGTATCGACACGCTGGGGTTAAAACCCACCCAACGGGAACATTTGCTCGATCAGATTGAGGAAGTACTGGTGGCTTTACGGCGGGTGATTCGGGCCACCGACTTGCACTCAAAGTATCTGGTTAAAACCACCAGTTTGACGGCGCCACAGATTTTGTTACTACAAACTTTGCGTGATAAGGGCCAGTTAACTATTGGTGAACTGGCGCAGGATATGAGTCTGAGTCAGGCAACCGTCACCACTATTTTAGACCGGCTGGAAAAACGCCAACTGGTGTATCGGCAACGTTCGCAGACCGATAAACGCAAAGTCCACGCCTATATGACTGATGAAGCCATGACGATGCTGAAAAATGCGCCGATTCCGCTGCAGGATCGTTTCACCCGTGAATTCAGTCAATTGCAGGAATGGGAACAAACCATGATCATTTCATCGCTGAAACGGGTCGCCCAAATGATGGATGCCAAACCGCTGACGTCAGCGGCTGAGGTATCGCAGCAGATAAATGAAGACAAGACGGCAGCTGAATCTCGCTGA	MEKSDNRNTTSIDTLGLKPTQREHLLDQIEEVLVALRRVIRATDLHSKYLVKTTSLTAPQILLLQTLRDKGQLTIGELAQDMSLSQATVTTILDRLEKRQLVYRQRSQTDKRKVHAYMTDEAMTMLKNAPIPLQDRFTREFSQLQEWEQTMIISSLKRVAQMMDAKPLTSAAEVSQQINEDKTAAESR	MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVTELALDTGTVSPLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKELNRLLGKVIHAFDETKEK	127.89	gnl|BL_ORD_ID|133|hsp_num:0	154			75	336	methicillin; ciprofloxacin; acriflavine; tetracycline; daptomycin; moxifloxacin; cefotaxime; norfloxacin; sparfloxacin; moenomycin A1
BGC0000857.1|Ectoine_3 # 1136 # 1654 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.474	BGC0000857.1|Ectoine_3 	1136	1654	+	Loose	300	34.2686	AAC(3)-Ic	26.67	3002531	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGCAAGCAGTTAAACAAAACACTTCCCCGATCACCTTAATCCAGCCAACCGCTGAAATCGGCGCGCAGGTGTATCAATTAATTGCCAATTGTCCGCCACTGGATACCAACTCTATGTATTGCAATTTGTTGCAAAGCAGTCATTTTGCAGAAACAGCCGTTGCTGCCATGCTGGATGAAGAAGTGGTGGGCTTTATCTCAGGCTATCGGATACCGCAACGCCCTGACAGTTTGTTTGTCTGGCAGGTTGCAGTGGGGGAAAAGGCCAGAGGGCAGGGGCTGGCGACGCAGATGTTGAAAGCCATTTTATCGCGGCCTGAAAATCAGGATATTAAACGAATTGAAACAACGATCACCCCTGACAATCGTGCCTCATGGGCGTTATTTGAAGGACTGGCGAGAAAGCTGGATACTGAAATTTCCAGCAGTGTGATGTTTGATAAAACTACACATTTTGCCGATCAACATGCATCAGAAATGCTGGTGAAAGTGGGGCCGTTCAAGTCCCAGAAACTGTAA	MQAVKQNTSPITLIQPTAEIGAQVYQLIANCPPLDTNSMYCNLLQSSHFAETAVAAMLDEEVVGFISGYRIPQRPDSLFVWQVAVGEKARGQGLATQMLKAILSRPENQDIKRIETTITPDNRASWALFEGLARKLDTEISSSVMFDKTTHFADQHASEMLVKVGPFKSQKL	MISTQTKITRLNSQDVGVMRAMLGMFGEAFEDAENYCRAQPSDSYLQDLLCGSGFIAIAALQGQEVIGGLAAYVLPKFEQQRKEIYIYDLGVQGAYRRRGIATALINELQRIAHDIGAYVIFVQADYGDDPAVALYTKLGIREDVMHFDIEPQPAA	110.26	gnl|BL_ORD_ID|1035|hsp_num:0	1131			108	327	astromicin; sisomicin; gentamicin
BGC0000857.1|Ectoine_6 # 3558 # 4871 # 1 # ID=1_6;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.467	BGC0000857.1|Ectoine_6 	3558	4871	+	Loose	450	32.3426	vanS gene in vanD cluster	31.58	3002934	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGGATTTTCATACCGTTGAAAAAATTGGCGGCACATCAATGAGTGATTATGTTGCCGTGCGTGACAATGTCATTTTAAAGCCAGTTCATTCAACGTCTTTGTATCAACGCATTTTTGTGGTTTCGGCTTACGGGGGCATTACCAACCTGTTACTGGAACATAAAAAGAATGGTCAGGCGGGTATTTATGGCCAGTTTGCCAACAGCGTCAATGATGATGGTTGGCAAGCGTCTTTGGAGCAGTTGAAACAAGAAATGCTGGCGATTAATGCCACCTTGTTTGATAGCGCAGAAACCATTGCCAAAGCGGATGCCTTTATCAGCGAGCGTCTGGATGATACCGAACGCTGTTTAGCGGATCTGCAACGGCTGTGTCAGCATGGCCATTTTTCTTTAGATGGTCACCTCGCCACTGTACGGGAAATGCTGGCCAGTATCGGTGAAGCCCACAGTGCCTGGAATACTGTTCAGCTATTACAGCAGGATGATATTAATGCGGTGTTTGTGGATTTGACCGGTTGGCAAACCGATAAGCATATGACGCTGGATGAACGGATCGAAACGGCTTTTGCCAAGATTGATCTCAATACCCAATTACCCATTGTCACCGGTTATGCTCACAGTATTGATGGATTGATGTCGACCTTTGACCGGGGTTACAGCGAAATGACGTTCAGTCGTTTAGCGGTGTTAACCAATGCGAATGAAGCCATTATTCATAAAGAATTCCATTTAAGCAGTGCGGATCCGCGCTTGGTGGGCGAAGACAATGCGGTGCCGATTGGCCGTACCAACTACGATGTAGCCGACCAGCTGGCAAATCTGGGGATGGAAGCCATTCATCCGAAAGCGGCCAAAGGTCTGCGTAAAAATGAGATTCCGTTACGGGTTCGTAATACCTTTGAACCAGAACATGCGGGCACGTTGATTACTGGTGATTATGTCAGCAGCAAGCCCTGTGTTGAGATTATTGCTGGTTGTAAAGGCGTTTATGCTTTTGAAGTATTTGATCAGGATATGGCAGGCGAAATTGATAGCTACGACAAAGAGATCCTGGCGCAAATCCGCCGCTTTAAAGCGCATATCGTCTCTAAAGACATTAATGCCAATACCATTACGCATTACCTTACCGCGAGTCTGAAAAAAATCCGCCGTATTCGTGATGCGCTGCAGGAACGTTTTCCGGATGCTGAAATCAATCAGCAGAAAGTGGCGATTGTATCGGCCATTGGCAGTGATATGAAAATCCCCGGCATTCTGGCAAAAACGGTCGCGGCATTGGCAGAGAAAAATATCAGTGTACTGGCGATGCAT	MDFHTVEKIGGTSMSDYVAVRDNVILKPVHSTSLYQRIFVVSAYGGITNLLLEHKKNGQAGIYGQFANSVNDDGWQASLEQLKQEMLAINATLFDSAETIAKADAFISERLDDTERCLADLQRLCQHGHFSLDGHLATVREMLASIGEAHSAWNTVQLLQQDDINAVFVDLTGWQTDKHMTLDERIETAFAKIDLNTQLPIVTGYAHSIDGLMSTFDRGYSEMTFSRLAVLTNANEAIIHKEFHLSSADPRLVGEDNAVPIGRTNYDVADQLANLGMEAIHPKAAKGLRKNEIPLRVRNTFEPEHAGTLITGDYVSSKPCVEIIAGCKGVYAFEVFDQDMAGEIDSYDKEILAQIRRFKAHIVSKDINANTITHYLTASLKKIRRIRDALQERFPDAEINQQKVAIVSAIGSDMKIPGILAKTVAALAEKNISVLAMH	MKNRNKTSHEDDYLLFKNRLSVKILLMMACSILIIAGVYLFILKDNFANVVVAILDSFIYHDRDEAVVVYLRTFKAYEIWLFLIAVMGVFFMIFRRYLDSISKYFKEINRGIDTLVNEDANDITLPPELASTERKINSIRHTLTKRKTDAELAEQRKNDLVMYLAHDLKTPLSSVIGYLNLLRDENQISEELREKYLSISLDKAERLEELINEFFEITRLIFQISRLCTAKSI	187.98	gnl|BL_ORD_ID|2055|hsp_num:0	2139			246	513	vancomycin; teicoplanin
